Q4 2024 electroCore, Inc. Earnings Call Transcript
Key Points
- ElectroCore Inc (ECOR) reported a 57% increase in revenue for 2024, reaching $25.2 million, driven by growth in both prescription and non-prescription product lines.
- The company achieved a gross margin of 85% for the full year 2024, up from 83% in 2023, indicating improved profitability.
- Sales in the VA channel grew significantly, with an 85% increase to $17.8 million for the full year 2024, highlighting strong demand in this segment.
- The Truvaga brand saw a 174% increase in net sales for 2024, demonstrating successful expansion in the direct-to-consumer wellness market.
- ElectroCore Inc (ECOR) is making progress towards positive cash flow from operations and GAAP profitability, with a 37% reduction in net loss for the year.
- The US prescription gammaCore channel recorded a 15% decline in revenue for 2024, indicating challenges in this segment.
- The acquisition process for TAC-STIM with the Department of Defense is lengthy and opaque, making revenue from this product line hard to predict.
- The Joerns Healthcare channel has been slower to gain traction than anticipated, with only modest progress in prescription volumes.
- Revenue from channels outside the United States remained flat, suggesting limited growth in international markets.
- The company is refraining from providing guidance for 2025 pending the close of the NeuroMetrix acquisition, creating uncertainty about future performance.
Greetings and welcome to the electroCore fourth-quarter and full-year 2024 earnings conference call. As part of our ongoing efforts to reduce costs and drive profitability, management has opted to host this earnings call on Zoom rather than using a more costly service provider.
This will be our first time hosting the call independently, so we appreciate your patience as we work through any potential technical issues. (Operator Instructions) As a reminder, this conference call is being recorded.
It is now my pleasure to introduce your host, Dan Goldberger, electroCore's Chief Executive Officer.
Thank you, all, for participating in today's electroCore earnings call. Joining me today is Josh Lev, our Chief Financial Officer, and our investor relations firm, FNK IR. Earlier today, electroCore published results for the fourth quarter and full year ended December 31, 2024. A copy of the press release is available on the company's website. I apologize for the late start this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
